# Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke

> **NCT07163702** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 60 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** High-dose Xinglou Chengqi granules
- **DRUG:** Low-dose Xinglou Chengqi granules and placebo

## Key facts

- **NCT ID:** NCT07163702
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07163702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07163702, "Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07163702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*